| Serial Number | 86370062 |
| Word Mark | BTG |
| Filing Date | Monday, August 18, 2014 |
| Status | 702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Tuesday, April 11, 2023 |
| Registration Number | 4962342 |
| Registration Date | Tuesday, May 24, 2016 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 7, 2015 |
| Goods and Services | Pharmaceutical, medicinal and veterinary preparations and substances, namely, vaccines, antitoxic sera, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations and substances for the treatment of thrombosis, embolisms, inflammation, and autoimmune disease, pharmaceutical preparations for the treatment of envenomation by snakes, veterinary preparations for the treatment of envenomation by snakes, and dietetic foods adapted for medical use, namely, food supplements containing vitamins, minerals, trace elements, oils and fats, either apart or in combinations thereof for use in the treatment of cardiovascular issues, vascular issues or cancer, liquid medical sealants, and liquid adhesives for use in surgical and clinical procedure; pharmaceutical and medicinal preparations and substances, namely, vaccines and vaccine adjuvants, proteins, peptides, sera containing polyclonal antibodies and fragments thereof and polyclonal antibodies and fragments derived therefrom all for use in treating snake envenomation, overdose of toxic substances, and sepsis; drug delivery agents, namely, preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolisation; pharmaceutical preparations and substances for embolisation of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical and veterinary purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemico-pharmaceutical preparations for the treatment of envenomation by snakes; chemical preparations for medical and pharmaceutical purposes for the treatment of envenomation by snakes; medicines for the treatment of envenomation by snakes; pharmaceutical and veterinary preparations for the treatment of digoxin, digitalis and other cardio-active glycoside toxicity; pharmaceutical and veterinary preparations for the treatment of pre-eclampsia; chemical reagents for medical and veterinary therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for use in the treatment of digoxin, digitalis and other cardio-active glycoside toxicity, and for use in the treatment of pre-eclampsia; chemical preparations for medical and pharmaceutical purposes and medicines for use in the treatment of digoxin, digitalis and other cardio-active glycoside toxicity and for use in the treatment of pre-eclampsia; transarterial chemoembolisation pharmaceutical preparations, vaccines and sera; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, therapeutic agents for delivery of radioactive materials to target sites within the body for the treatment of cancer; irradiated and radioactive microspheres used for in vivo therapeutic medical purposes, namely, beads in the nature of microscopic glass beads impregnated with radioactive pharmaceutical preparations for treatment of cancerous tumors; radiotherapy substances for medical purposes, namely, radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiopharmaceuticals, namely, radiopharmaceuticals for the treatment of cancer and radiopharmaceutical preparations for use in nuclear medicine; therapeutic agents for delivery of radioactive material to target sites within the body; beads, including microscopic radioactive beads featuring pharmaceutical preparations for treatment of cancerous tumours; beads, including microscopic glass beads, impregnated with radioactive pharmaceutical preparations and consisting of radioactive material for treatment of cancerous tumours; radioactive glass beads impregnated with pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use with ultrasound waves to enhance drug delivery and medically activate drugs; pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams and for use in preparing foams, for sclerotherapy, phlebology, angiology and proctology, namely, for the treatment of oesophageal varices, hydroceles, in sterilisation treatment and for treatment of varicose veins, and arterio-venous malformations; pharmaceutical preparations containing methotrexate antidotes; pharmaceutical preparations containing 5-fluorouracil antidotes; pharmaceutical preparations for use in chemotherapy and for the treatment of autoimmune diseases; pharmaceutical preparations used for regulating toxicity levels of therapeutic agents; pharmaceutical preparations used for depleting concentrations of therapeutic agents |
| Goods and Services | Surgical, medical and veterinary apparatus and instruments, namely, medical syringes, surgical and medical apparatus for producing and administering pharmaceutical foams, surgical and medical apparatus for producing foams for treatment of varicose veins, arterio-venous malformations, oesophageal varices and hydroceles, devices for intravenous administration of pharmaceutical foam, and diagnostic devices for grading the severity of venous conditions, snake envenomation and toxic drugs overdose; surgical, medical and veterinary apparatus and instruments, namely, medical devices for use in pulmonary and thoracic surgery and procedures, lung air trapping reduction coils, lung volume reduction devices, surgical implants comprising artificial material, surgical implants comprising artificial materials for restoring, maintaining and improving patient breathing and artificial surgical implants for restoring, maintaining and improving lung function, and catheters for deploying these; surgical, medical and veterinary apparatus and instruments, namely, medical device, apparatus and instruments for treating cancer; drug delivery embolisation apparatus, instruments and systems; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical apparatus and instruments for embolisation; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolization, namely, embolic devices for use in treating cancer and tumors, embolic devices for treating arteriovenous malformations (AVMs) of the body, and embolic devices for use in treating tumors; drug delivery embolisation systems; drug delivery apparatus and instruments namely, a drug delivery system comprised of injection syringes and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; medical apparatus and instruments for embolization, namely, medical devices in the nature of embolic microspheres for embolization; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body; beads, namely, microscopic radioactive glass beads administered surgically for treatment of cancerous tumours; radioactive beads, namely, radioactive glass beads administered for treatment of cancerous tumours; surgical and medical apparatus and instruments for use in the circulatory system; medical devices in the nature of drug delivery systems which use ultrasound to enhance drug delivery and medically activate drugs; catheters for delivery of drugs and fluids sold together as a unit with controllers and power units for infusion catheters; ultrasonic drug delivery and drug activation apparatus sold together as a unit with controllers and power units therefor; needles for medical use, namely, cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering sclerosing foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for use in sclerotherapy, phlebology, angiology and proctology; syringes for producing and administering foams for use in sclerotherapy, phlebology, angiology and proctology; surgical and medical apparatus for administering and producing foams for use in sterilisation treatment; surgical and medical apparatus for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices and hycroceles; syringes for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices and hydroceles; devices for assessing the physical characteristics of such foams, namely, medical diagnostic apparatus for analyzing the efficacy of sclerotherapy foams for medical purposes; medical devices for intravenous administration of sclerosing foam for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical devices for monitoring the position and effect of sclerosing foam in the human body for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical diagnostic apparatus for diagnosing all the above medical conditions, namely, varicose veins, arterio-venous malformations, oesophageal varices, spider veins hydroceles, cancer, tumors, and circulatory system conditions and pulmonary and thoracic conditions; compression bandages; component parts and fittings for all of the aforesaid goods; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes, namely, implantable radiation therapy devices consisting of radioactive beads in the nature of microscopic radioactive beads for treatment of cancerous tumours; implantable radiation therapy devices consisting of radioactive beads and a bioabsorbable carrier assembly, namely, beads in the nature of microscopic radioactive beads for treatment of cancerous tumours and beads in the nature of radioactive microscopic glass beads for treatment of cancerous tumours; radioactive glass beads, namely, implantable radiation therapy devices consisting of radioactive beads and a bioabsorbable carrier assembly and implantable radiation therapy devices consisting of radioactive beads; radioactive glass beads, namely, implantable radiation therapy devices consisting of radioactive glass beads administered for treatment of cancerous tumours |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 29, 2014 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 29, 2014 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | PROTHERICS MEDICINES DEVELOPMENT LIMITED |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | London EC4V6JA GB |
| Party Name | BTG International Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | London EC4M7RD GB |
| Party Name | BTG International Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | London EC4M 7RD GB |
| Party Name | BTG International Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | London EC4M 7RD GB |
| Event Date | Event Description |
| Thursday, July 13, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, July 13, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, July 13, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, April 11, 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Tuesday, April 11, 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Friday, April 7, 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Thursday, March 16, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, March 16, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, March 16, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, March 16, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, March 16, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, September 28, 2022 | TEAS SECTION 8 & 15 RECEIVED |
| Tuesday, April 12, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, April 12, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, April 12, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Tuesday, April 12, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, April 12, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, April 12, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, August 30, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, August 30, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, August 30, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, August 30, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, August 30, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, May 24, 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Thursday, April 22, 2021 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Saturday, August 29, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Saturday, August 29, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Saturday, August 29, 2020 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
| Saturday, August 29, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Saturday, August 29, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Saturday, August 29, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, May 24, 2016 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, April 14, 2016 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Monday, February 22, 2016 | NOTICE OF ALLOWANCE CANCELLED |
| Sunday, April 3, 2016 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, February 22, 2016 | TEAS DELETE 1(B) BASIS RECEIVED |
| Tuesday, September 1, 2015 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 7, 2015 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 7, 2015 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 17, 2015 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, June 1, 2015 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, June 1, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, May 28, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 27, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 27, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 13, 2015 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Monday, April 13, 2015 | PRIORITY ACTION E-MAILED |
| Monday, April 13, 2015 | PRIORITY ACTION WRITTEN |
| Saturday, March 21, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, March 20, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 20, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, November 21, 2014 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, November 21, 2014 | NON-FINAL ACTION E-MAILED |
| Friday, November 21, 2014 | NON-FINAL ACTION WRITTEN |
| Friday, November 14, 2014 | ASSIGNED TO EXAMINER |
| Friday, August 29, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 29, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, August 29, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 22, 2014 | ASSIGNED TO LIE |
| Thursday, August 21, 2014 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Thursday, August 21, 2014 | NEW APPLICATION ENTERED |